Clinically validated ocular revitalization serum with 2mg/ml medical-grade salmon-derived polynucleotides and hyaluronic acid matrix. Demonstrated 86% wound closure efficacy in clinical trials, with 89% users reporting improved dermal density after 3 sessions. FDA-compliant manufacturing process ensures pharmaceutical-grade purity.

Core Advantages

Biotechnological Components

Clinical Protocol

*For licensed practitioners only. Individual results may vary based on skin physiology and application technique. Contraindicated during pregnancy and active dermatological conditions. Clinical data from 2023 trial with 142 participants. Storage at 2-8°C required.